These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27102110)
1. Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations. Fasehee H; Dinarvand R; Ghavamzadeh A; Esfandyari-Manesh M; Moradian H; Faghihi S; Ghaffari SH J Nanobiotechnology; 2016 Apr; 14():32. PubMed ID: 27102110 [TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes. Fasehee H; Zarrinrad G; Tavangar SM; Ghaffari SH; Faghihi S Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():587-95. PubMed ID: 27040254 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity. Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812 [TBL] [Abstract][Full Text] [Related]
5. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372 [TBL] [Abstract][Full Text] [Related]
6. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
7. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
9. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells. Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314 [TBL] [Abstract][Full Text] [Related]
10. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286 [TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867 [TBL] [Abstract][Full Text] [Related]
12. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles. Kuo YC; Chen YC Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309 [TBL] [Abstract][Full Text] [Related]
13. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells. Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655 [TBL] [Abstract][Full Text] [Related]
14. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation. Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496 [TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
16. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Zhang Z; Huey Lee S; Feng SS Biomaterials; 2007 Apr; 28(10):1889-99. PubMed ID: 17197019 [TBL] [Abstract][Full Text] [Related]
17. Novel nanosystem to enhance the antitumor activity of lapatinib in breast cancer treatment: Therapeutic efficacy evaluation. Huo ZJ; Wang SJ; Wang ZQ; Zuo WS; Liu P; Pang B; Liu K Cancer Sci; 2015 Oct; 106(10):1429-37. PubMed ID: 26177628 [TBL] [Abstract][Full Text] [Related]
18. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting. Zhao H; Yung LY J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763 [TBL] [Abstract][Full Text] [Related]
19. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
20. Influence of stabilizers on the production of disulfiram-loaded poly(lactic-co-glycolic acid) nanoparticles and their anticancer potential. Hoda M; Sufi SA; Shakya G; Kumar KM; Rajagopalan R Ther Deliv; 2015 Jan; 6(1):17-25. PubMed ID: 25565438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]